z-logo
open-access-imgOpen Access
The Prognosis of Single Large Hepatocellular Carcinoma Was Distinct from Barcelona Clinic Liver Cancer Stage A or B: The Role of Albumin-Bilirubin Grade
Author(s) -
KuanChieh Fang,
WeiYu Kao,
ChienWei Su,
PoChun Chen,
Pei-Chang Lee,
YiHsiang Huang,
Teh–Ia Huo,
ChunChao Chang,
Ming-Chih Hou,
HanChieh Lin,
JawChing Wu
Publication year - 2018
Publication title -
liver cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.916
H-Index - 34
eISSN - 2235-1795
pISSN - 1664-5553
DOI - 10.1159/000487407
Subject(s) - hepatocellular carcinoma , medicine , gastroenterology , liver cancer , bilirubin , creatinine , stage (stratigraphy) , albumin , biology , paleontology
Whether single large hepatocellular carcinoma (SLHCC) is classified as Barcelona Clinic Liver Cancer (BCLC) stage A or B is still controversial. We aimed to compare the clinical manifestations, treatment modalities, and prognoses among patients with SLHCC and those in BCLC stage A and B.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom